On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

BACKGROUND: Diabetes mellitus and high platelet reactivity (HPR) on clopidogrel are both associated with increased risk of ischemic events after percutaneous coronary intervention, but whether the HPR‐associated risk of adverse ischemic events differs by diabetes mellitus status is unknown. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahim, Bahira, Redfors, Björn, Stuckey, Thomas D., Liu, Mengdan, Zhou, Zhipeng, Witzenbichler, Bernhard, Weisz, Giora, Rinaldi, Michael J., Neumann, Franz‐Josef, Metzger, D. Christopher, Henry, Timothy D., Cox, David A., Duffy, Peter L., Brodie, Bruce R., Srdanovic, Iva, Madhavan, Mahesh V., Mazzaferri, Ernest L., Mehran, Roxana, Ben‐Yehuda, Ori, Kirtane, Ajay J., Stone, Gregg W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973569/
https://www.ncbi.nlm.nih.gov/pubmed/36565189
http://dx.doi.org/10.1161/JAHA.122.026482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973569/
https://www.ncbi.nlm.nih.gov/pubmed/36565189
http://dx.doi.org/10.1161/JAHA.122.026482

Ejemplares similares